- Round ID
- FR-00553
- Stage
- Series B
- Round name
- Series B
- Amount
- $156M
Dated funding evidence
Quell Therapeutics
Series B · $156M · 2021-11-01
Reported round$156MSeries B
- Disclosure date
- 2021-11-01
- Reported currency
- USD
- Companies House
- 11890040
- Evidence sources
- 2
2021-11-01Series B$156M
Resolved investor records
Jeito CapitalLead investorRidgeback Capital InvestmentsLead investorSV Health InvestorsLead investorFidelity Management & Research CompanyLead investorSynconaInvestor
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Jeito Capital, Ridgeback Capital Investments, SV Health Investors, Fidelity Management & Research Company
- Other investors
- Syncona
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.